Carried hepatitis B among Libyan patients who attended the Al Zawia street hospital
1 Student at a memorial university, Biochemistry department. Canada.
2 Higher institute of science and medical technology/ Jado, Libya.
Research Article
GSC Biological and Pharmaceutical Sciences, 2020, 13(01), 062-066.
Article DOI: 10.30574/gscbps.2020.13.1.0312
Publication history:
Received on 26 September 2020; revised on 05 October 2020; accepted on 10 October 2020
Abstract:
Hepatitis B (HBV) is a significant liver disease that affects roughly 400 million individuals globally with chronic infection, leading to liver cirrhosis or carcinoma. The virus can spread through blood transfusion, sexual contact, or the use of contaminated needles. HBV is more prevalent in developing countries than developed ones. However, it is estimated that 5% to 10% of the global population carry the virus, whereas, in North America and western Europe, only 1% of the people have a chronic infection. Our objective is to determine the prevalence of HBV and identify the disease’s risk factors. We conducted a statistical study, and data were collected through the Al Zzawia street hospital from November 1, 2010, to January 1, 2011. Our results concluded that the prevalence of HbsAg was higher in 2005 than in 2010. HBV was also found to be more prevalent in males than in females. As a result, more attention and guidance, especially for young people, could reduce the spread drastically.
Keywords:
HBV; Liver; Virus; Infection
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
